REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 130 filers reported holding REVOLUTION MEDICINES INC in Q1 2021. The put-call ratio across all filers is 0.05 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,476,498 | +409.6% | 342,359 | +392.5% | 0.01% | +450.0% |
| Q2 2023 | $1,859,420 | +89.0% | 69,511 | +53.1% | 0.00% | +100.0% |
| Q1 2023 | $983,581 | -14.5% | 45,410 | -5.9% | 0.00% | 0.0% |
| Q4 2022 | $1,149,791 | +131.3% | 48,270 | +91.5% | 0.00% | 0.0% |
| Q3 2022 | $497,000 | +144.8% | 25,200 | +240.7% | 0.00% | – |
| Q3 2021 | $203,000 | -17.5% | 7,396 | -4.6% | 0.00% | – |
| Q2 2021 | $246,000 | -99.3% | 7,753 | -99.0% | 0.00% | -100.0% |
| Q1 2021 | $34,680,000 | +1709.1% | 755,864 | +1461.5% | 0.04% | +1700.0% |
| Q4 2020 | $1,917,000 | -1.6% | 48,405 | -13.5% | 0.00% | -33.3% |
| Q3 2020 | $1,948,000 | +218.3% | 55,983 | +188.7% | 0.00% | +200.0% |
| Q2 2020 | $612,000 | -78.0% | 19,390 | -84.8% | 0.00% | -50.0% |
| Q1 2020 | $2,788,000 | – | 127,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |